Cargando…

Levels of TB-IGRA may help to differentiate between intestinal tuberculosis and Crohn’s disease in patients with positive results

AIM: The aim of this study was to investigate the significance of positive tuberculosis interferon gamma release assay (TB-IGRA) in the differential diagnosis of intestinal tuberculosis (ITB) and Crohn’s disease (CD) patients, and to find a suitable threshold to help distinguishing CD from tuberculo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yujie, Xu, Meilin, Chen, Liang, Liu, Zhanju, Sun, Xiaomin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Noninvasive monitoring of disease activity and complications in Crohn’s disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235651/ https://www.ncbi.nlm.nih.gov/pubmed/32523624 http://dx.doi.org/10.1177/1756284820922003

Ejemplares similares

Change in bowel habits during menstruation: are IBD patients different?
por: Lahat, Adi, et al.
Publicado: (2020)

The accuracy of intestinal ultrasound compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileocolonoscopy
por: Carter, Dan, et al.
Publicado: (2018)

The Lewis score or the capsule endoscopy Crohn’s disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn’s disease?
por: Yablecovitch, Doron, et al.
Publicado: (2018)

Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease
por: Chen, Rirong, et al.
Publicado: (2020)

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease
por: Dulai, Parambir S., et al.
Publicado: (2019)

Exposure‐response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease
por: Vande Casteele, N., et al.
Publicado: (2017)

Long‐term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy
por: Sandborn, W. J., et al.
Publicado: (2018)

Impact of patient characteristics on the clinical efficacy of mongersen (GED‐0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease
por: Monteleone, G., et al.
Publicado: (2016)

Long‐term safety and tolerability of oral tofacitinib in patients with Crohn’s disease: results from a phase 2, open‐label, 48‐week extension study
por: Panés, Julián, et al.
Publicado: (2019)

Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn’s disease
por: Lansdorp, Corine A., et al.
Publicado: (2020)

Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease
por: Bohm, Matthew, et al.
Publicado: (2020)

Toward transmural healing: Sonographic healing is associated with improved long‐term outcomes in patients with Crohn’s disease
por: Vaughan, Rose, et al.
Publicado: (2022)

Association between high dietary intake of the n−3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease
por: Chan, S. S. M., et al.
Publicado: (2014)

A retrospective cohort study: pre‐operative oral enteral nutritional optimisation for Crohnʼs disease in a UK tertiary IBD centre
por: Meade, Susanna, et al.
Publicado: (2022)

Crohn's disease of the gastrointestinal tract /
por: Schachter, Howard
Publicado: (1980)

Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Long‐term safety of vedolizumab for inflammatory bowel disease
por: Loftus, Edward V., et al.
Publicado: (2020)

Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre cohort study
por: Asscher, Vera E. R., et al.
Publicado: (2020)

A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II
por: Lenti, Marco Vincenzo, et al.
Publicado: (2021)

Intestinal Tuberculosis and Crohn’s Disease is Always a Diagnostic Challenge: A Case Report and Review of the Literature on the Importance of Fecal Mycobacterial Cultures and the Limitations of Latent Infection Testing
por: Kurnick, Adam, et al.
Publicado: (2019)

Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease
por: van Haaften, W. T., et al.
Publicado: (2017)

Low-Dose (10%) Computed Tomography May Be Inferior to Standard-Dose CT in the Evaluation of Acute Renal Colic in the Emergency Room Setting
por: Malkawi, Ibraheem M., et al.
Publicado: (2016)

Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review protocol
por: Bunyasi, Erick Wekesa, et al.
Publicado: (2017)

Tuberculosis contact investigation in African Portuguese-speaking countries at End TB Strategy era: a scoping review
por: Loesch, Regina Becker Reifschneider, et al.
Publicado: (2022)

IGRA test for TB in COVID-19: role of corticosteroids
por: Granozzi, B., et al.
Publicado: (2022)

Latent tuberculosis infection screening and treatment in congregate settings (TB FREE COREA): protocol for a prospective observational study in Korea
por: Min, Jinsoo, et al.
Publicado: (2020)

Creeping fat formation and interaction with intestinal disease in Crohn's disease
por: Yin, Yi, et al.
Publicado: (2022)

Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting
por: Sharma, Surendra K., et al.
Publicado: (2017)

Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study
por: Sack, Stefan, et al.
Publicado: (2011)

Hybrid approaches to clinical trial monitoring: Practical alternatives to 100% source data verification
por: De, Sourabh
Publicado: (2011)

A day in the life of a monitor!
por: Shah, Kunal
Publicado: (2012)

Biocrust morphogroups provide an effective and rapid assessment tool for drylands
por: Read, Cassia F., et al.
Publicado: (2014)

FORUM: Ecological networks: the missing links in biomonitoring science
por: Gray, Clare, et al.
Publicado: (2014)

Tree‐centric mapping of forest carbon density from airborne laser scanning and hyperspectral data
por: Dalponte, Michele, et al.
Publicado: (2016)

Accuracy and consequences of using trial-of-antibiotics for TB diagnosis (ACT-TB study): protocol for a randomised controlled clinical trial
por: Divala, Titus Henry, et al.
Publicado: (2020)

Randomised controlled trial to evaluate the effectiveness of using the RD-1-based C-Tb skin test as a replacement for blood-based interferon-γ release assay for detection of, and initiation of preventive treatment for, tuberculosis infection: RID-TB:Dx study protocol
por: Rangaka, Molebogeng X, et al.
Publicado: (2021)

The Uterine Immune Profile May Help Women With Repeated Unexplained Embryo Implantation Failure After In Vitro Fertilization
por: Lédée, Nathalie, et al.
Publicado: (2016)

Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: a community-based study in Taiwan
por: Kuo, Shu-Chen, et al.
Publicado: (2019)

Primary Extrapulmonary Rifampicin Mono-Resistant Tuberculosis (TB) of the Endometrium in a Sexually Inactive 20-Year-Old Indian Female: A Very Rare Case
por: Yadav, Sankalp
Publicado: (2022)

Analysis of 61 exclusive enteral nutrition formulas used in the management of active Crohn’s disease—new insights into dietary disease triggers
por: Logan, Michael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rh6old7brh09b0g31b5bbv14kq